Punch & Associates Investment Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.5M | Buy |
595,963
+22,360
| +4% | +$806K | 1.32% | 16 |
|
|
2025
Q1 | $17.9M | Buy |
573,603
+101,390
| +21% | +$3.16M | 1.17% | 20 |
|
|
2024
Q4 | $12M | Buy |
472,213
+11,162
| +2% | +$285K | 0.66% | 58 |
|
|
2024
Q3 | $13M | Buy |
461,051
+36,510
| +9% | +$1.03M | 0.72% | 45 |
|
|
2024
Q2 | $11.2M | Buy |
424,541
+55,625
| +15% | +$1.47M | 0.65% | 55 |
|
|
2024
Q1 | $11.2M | Buy |
+368,916
| New | +$11.2M | 0.64% | 59 |
|